Status:

COMPLETED

Rhinological Outcomes in Endonasal Pituitary Surgery

Lead Sponsor:

St. Joseph's Hospital and Medical Center, Phoenix

Conditions:

Pituitary Neoplasm

Pituitary Adenoma

Eligibility:

All Genders

18-80 years

Brief Summary

This is a prospective, multi-center observational study designed to address patient-reported nasal outcomes in adults undergoing endoscopic and microscopic surgical removal of pituitary tumors. The pr...

Detailed Description

The technical and patient factors that influence rhinological (nasal) outcomes following endonasal anterior skull base surgery and pituitary surgery are not well understood. Several timely and controv...

Eligibility Criteria

Inclusion

  • Pituitary tumor patients treated by transsphenoidal route
  • Adults (age 18-80 years)
  • Direct endonasal or endoscopic approach
  • Non-functioning adenoma, Cushing's disease, acromegaly

Exclusion

  • Patients treated by expanded endonasal approaches (transtubercular approach)
  • Sublabial approach

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 9 2015

Estimated Enrollment :

235 Patients enrolled

Trial Details

Trial ID

NCT01504399

Start Date

October 1 2011

End Date

December 9 2015

Last Update

August 22 2018

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Barrow Neurological Institute/St. Joseph's Hospital and Medical Center

Phoenix, Arizona, United States, 85013

2

John Wayne Cancer Institute at St. John's Health Center

Santa Monica, California, United States, 90404

3

Northshore University Health System

Chicago, Illinois, United States, 60640

4

Ohio State University Medical Center

Columbus, Ohio, United States, 43210